During the six months ended June 30, 2025, the global economy continued to trend toward recovery, though uncertainty over the future heightened due to developments relating to the U.S. tariff policies and geopolitical risks. In the United States, the economy slightly slowed but remained firm due to widespread uncertainty concerning tariff policies. In Europe, the economy trended toward recovery against the backdrop of a rush demand before the imposition of the additional U.S. tariffs and an increase in consumer spending. In China, although the economy showed a moderate recovery driven by government economic stimulus measures, foreign demand remained sluggish, and the overall economic recovery lacked momentum. Meanwhile, the Japanese economy showed signs of a moderate recovery, constrained by sluggish external demand and other factors.
Under these conditions, during the six months ended June 30, 2025, product demand remained steady in the Industrial Materials and the Medical Technologies segments, and the company acquired in the pharmaceutical business during the current period begun to contribute to earnings. In the Devices segment, product demand for tablets exceeded expectations due to a surge in purchase ahead of the implementation of the additional U.S. tariffs. However, it declined compared to the same period of the previous year, when demand was firm by new product launches. In addition to these, foreign exchange loss was recorded under other expenses.
As a result, regarding the financial results for the six months ended June 30, 2025, net sales were ¥97,049 million (a decrease of 2.6% as compared to the same period of the previous year), operating profit was ¥2,693 million (a decrease of 36.9% as compared to the same period of the previous year) and profit attributable to owners of parent was ¥129 million (a decrease of 97.0% as compared to the same period of the previous year).